We are delighted to announce that artist Annie Cattrell has been appointed as the public artist for the state-of-the-art research facility which will house over 500 scientists and clinicians from the UK DRI, UCL’s Queen Square Institute of Neurology (IoN) and UCLH’s National Hospital for Neurology and Neurosurgery (NHNN).
Read Article
Researchers led by UK DRI Centre Director Prof Julie Williams at Cardiff, have unveiled a new perspective on the potential triggers and drivers of Alzheimer’s disease (AD). Our growing knowledge of risk genes suggests multiple factors behind the condition, and clues for treatment development.
Read Article
A new UK DRI initiative to create an ‘atlas’ of the brain at different stages of Alzheimer’s disease is set to rapidly improve our understanding of the processes that lead to people developing the illness.
Read Article
Dr William McEwan, recently appointed Group Leader at UK DRI at Cambridge, has received the 2019 Lister Institute Research Prize for his work exploring protein aggregation in neurodegenerative diseases, and exploiting the immune system to develop treatments for these conditions.
Read Article
At the end of January, the lab of Prof Adrian Isaacs hosted the 2nd European C9orf72 workshop on at the UCL Queen Square Institute for Neurology in London. The focus of the meeting was to present novel unpublished data in order to increase collaboration and research impact across Europe.
Read Article
Following the recent general election pledge by The Conservative Party to double investment in dementia research to find treatments, Alzheimer’s Society have released five key priorities for spending over the next decade including continued investment in the UK DRI.
Read Article
A generous £5 million donation has been received from the Garfield Weston Foundation to support the planned development of the new state-of-the-art neuroscience centre at UCL. The building, which will be located on Gray’s Inn Road, will house over 500 researchers from the UK DRI and UCL’s Queen Square Institute of Neurology, all working towards the Government’s 2020 Challenge on Dementia.
Read Article
A pioneering collaboration between the UK DRI and the Medical Research Council’s Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) will use the very latest advances in technology to study rare cell populations and the role of proteins in diseases such as Alzheimer’s and Parkinson’s.
Read Article
A new report from the Global Council on Brain Health (GCBH) confirms that heart and brain health are connected, and that taking action to improve your cardiovascular health reduces the risk of cognitive decline and dementia. The Brain-Heart Connection summarises the strongest research on this topic and offers practical lifestyle tips people can take to protect their heart and brain health. We spoke to Prof Joanna Wardlaw, Group Leader at UK DRI at Edinburgh and expert contributor to the report, about the science and significance of the findings.
Read Article
We believe that collaboration will be at the heart of future breakthroughs for people affected by dementia. To stimulate productive new academic relationships, we recently launched our cross-centre postdoctoral researcher scheme and are delighted to announce the successful projects which span development of sophisticated new biomarkers to pioneering characterisation of synaptic changes in Alzheimer’s disease.
Read Article
It was today announced that an international trial investigating the potential of two drugs to slow memory loss and cognitive decline has failed to benefit people with a rare, inherited form of Alzheimer’s disease. The researchers will continue to analyse data and are hopeful that insights gained can inform future clinical trials in this area.
Read Article
UK DRI researcher Professor Paul Morgan has played a key role in a study that has identified a new protein linked to age-related macular degeneration (AMD). The finding could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone.
Read Article
Two new talented Fellows have been enlisted to our UK DRI centres based at Imperial College London, following a generous donation of £1.63 million from Lily Safra and the Edmond J. Safra Foundation. Dr Sarah Marzi and Dr Bing Li, will work closely with Prof Paul Matthews, UK DRI at Imperial, and Prof David Sharp, UK DRI Care Research & Technology respectively. Geneviève Timmins, Digital Communications Manager at Imperial College London, sat down with the recruits to find out more about their research into Parkinson's disease.
Read Article
As part of our ‘Neuroinflammation Theme’, we held a workshop in December that brought together researchers from across the institute and beyond to share expertise and best practice on the use of induced pluripotent stem cell (iPSC)-derived microglia. Delving into topics such as reproducibility, cell line characterisation and microglia phenotype and function, attendees discussed and agreed on actions that would benefit the whole of the field moving forward.
Read Article
We have a clearly defined goal at the UK DRI to develop effective therapeutics and technologies for dementia. Alongside building our disease knowledge over the coming years, we must also make progress in translating these discoveries into the clinic. But what are the practicalities of this? And is translation all about drug discovery?
Read Article
We believe our research is strengthened by input from people with lived experience of neurodegenerative diseases.
Read Article
Following the recent general election pledge by The Conservative Party to double investment in dementia research to find treatments, Alzheimer’s Research UK have released six key priorities for spending over the next decade including continued investment in the UK DRI.
Read Article
Published recently in Neuron, researchers from the UK DRI at Cambridge, led by Prof Giovanna Mallucci, have discovered a harmful reactivity state in astrocytes that compromises these cells’ ability to support neurons. Targeting this new profile may lead to novel therapeutics against the devastating neurodegenerative diseases behind dementia.
Read Article
The UK DRI is delighted to announce that we will partnering with the British Neuroscience Association (BNA) for their Festival of Neuroscience in 2021.
Read Article
If 2018 was the year we came to life, 2019 was the year we grew at pace and strengthened in all directions. And that’s all thanks to the hard work and original thinking of each and every one of you. So what did you achieve this year?
Read Article